We are live on
!
Find out more
IE
Israel Englander Millennium Management
AUM
$276B
1-Year Est. Return
44.8%
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
This Fund
S&P 500
This Quarter
Est. Return
+7.92%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$203B
AUM Growth
+$28.4B
(+16%)
Cap. Flow
+$3.36B
Cap. Flow
% of AUM
1.66%
Top 10 Holdings %
Top 10 Hldgs %
26.11%
Holding
7,181
New
870
Increased
2,213
Reduced
2,337
Closed
1,192
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
CALL
Ventas
VTR
$47.6B
| $4.7M | ﹤0.01% |
99,500
+22,000
| +28% | +$997K |
|
|
AMAM
2677
DELISTED
Ambrx Biopharma Inc
AMAM
| $4.7M | ﹤0.01% |
285,716
+274,727
| +2,500% | +$3.45M |
|
2678
Riskified
RSKD
$811M
| $4.7M | ﹤0.01% |
966,820
+283,295
| +41% | +$1.42M |
|
2679
CALL
AMC Entertainment Holdings
AMC
$2.4B
| $4.7M | ﹤0.01% |
106,760
-59,030
| -36% | -$2.92M |
|
|
EXK
2680
Endeavour Silver
EXK
$3.28B
| $4.69M | ﹤0.01% |
1,621,488
+201,184
| +14% | +$711K |
|
2681
Kiniksa Pharmaceuticals
KNSA
$6.15B
| $4.69M | ﹤0.01% |
332,746
-293,452
| -47% | -$3.93M |
|
|
INBX
2682
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $4.68M | ﹤0.01% |
180,348
-539,205
| -75% | -$12.6M |
|
|
HOLI
2683
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $4.68M | ﹤0.01% |
+265,922
| New | +$4.35M |
|
2684
iShares Floating Rate Bond ETF
FLOT
$10.6B
| $4.68M | ﹤0.01% |
92,026
+22,926
| +33% | +$1.16M |
|
2685
PUT
BILL Holdings
BILL
$4.93B
| $4.67M | ﹤0.01% |
+40,000
| New | +$3.8M |
|
|
IBTX
2686
DELISTED
Independent Bank Group, Inc.
IBTX
| $4.67M | ﹤0.01% |
135,333
+49,570
| +58% | +$1.84M |
|
2687
Invesco Leisure and Entertainment ETF
PEJ
$361M
| $4.66M | ﹤0.01% |
111,527
+34,100
| +44% | +$1.39M |
|
2688
Avita Medical
RCEL
$324M
| $4.66M | ﹤0.01% |
274,097
-61,379
| -18% | -$901K |
|
|
K
2689
CALL
DELISTED
Kellanova
K
| $4.66M | ﹤0.01% |
73,592
-1,065
| -1% | -$67.9K |
|
|
ESPR
2690
DELISTED
Esperion Therapeutics
ESPR
| $4.65M | ﹤0.01% |
3,346,726
-328,548
| -9% | -$459K |
|
|
CCVI
2691
DELISTED
Churchill Capital Corp VI
CCVI
| $4.63M | ﹤0.01% |
449,998
-583,252
| -56% | -$5.95M |
|
2692
Piper Sandler
PIPR
$5.29B
| $4.63M | ﹤0.01% |
143,304
+118,276
| +473% | +$3.91M |
|
|
EXAS
2693
PUT
DELISTED
Exact Sciences
EXAS
| $4.63M | ﹤0.01% |
+49,300
| New | +$3.85M |
|
|
KCGI
2694
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
| $4.63M | ﹤0.01% |
438,172
| – | – |
|
2695
Cato Corp
CATO
$53.3M
| $4.61M | ﹤0.01% |
574,608
-161,011
| -22% | -$1.34M |
|
2696
CALL
Motorola Solutions
MSI
$80.2B
| $4.6M | ﹤0.01% |
15,700
+14,700
| +1,470% | +$4.21M |
|
2697
CALL
KKR & Co
KKR
$98.8B
| $4.59M | ﹤0.01% |
81,900
+61,900
| +310% | +$3.24M |
|
2698
Ryder
R
$9.51B
| $4.58M | ﹤0.01% |
53,995
+34,923
| +183% | +$2.88M |
|
2699
Alto Ingredients
ALTO
$310M
| $4.58M | ﹤0.01% |
1,583,471
+1,444,209
| +1,037% | +$2.75M |
|
2700
Interface
TILE
$2.18B
| $4.57M | ﹤0.01% |
520,268
-414,716
| -44% | -$3.18M |
|
Similar funds
JT
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.